BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1713290)

  • 1. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 7. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How women cope with the results of maternal serum screening for fetal neural tube defects and Down syndrome].
    Kamerbeek LI; Roelofsen EE; Beekhuis JR; Tijmstra T; Mantingh A
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1308-11. PubMed ID: 7688449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W; Miny P; Schloo R; Tercanli S
    Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum screening of pregnant women for fetal neural tube defects and Down syndrome; initial experiences in The Netherlands].
    Beekhuis JR; Mantingh A; de Wolf BT; van Lith JM; Breed AS
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1303-7. PubMed ID: 7688448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal maternal serum profiles.
    Spencer K
    Br J Hosp Med; 1994 Mar 2-15; 51(5):243-6. PubMed ID: 7518729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.